Unknown

Dataset Information

0

A Novel Mutation of MAGEL2 in a Patient with Schaaf-Yang Syndrome and Hypopituitarism.


ABSTRACT: Introduction:Schaaf-Yang syndrome (SYS) is caused by truncating point mutations of the paternal allele of MAGEL2, an imprinted gene located in the critical region of Prader-Willi syndrome (PWS). These patients present a phenotype with neurodevelopmental delay, hypotonia, joint contractures, and a particularly high prevalence of autism (up to 75% in affected individuals). The loss of function of MAGEL2 is suggested to contribute to endocrine hypothalamic dysfunction in individuals with PWS. Case Presentation:The current study presented the case of a patient with SYS and a novel de novo truncating mutation of MAGEL2 and phenotypic characteristics typical of this Prader-Willi-like syndrome and also including partial hypopituitarism, hypothyroidism, growth hormone deficiency, and hyperprolactinemia. Conclusions:The clinical and molecular similarities between SYS and PWS suggested the need for a thorough endocrinological follow-up to improve the prognosis and long-term quality of life for patients with SYS.

SUBMITTER: D Hidalgo-Santos A 

PROVIDER: S-EPMC6176277 | biostudies-literature | 2018 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

A Novel Mutation of <i>MAGEL2</i> in a Patient with Schaaf-Yang Syndrome and Hypopituitarism.

D Hidalgo-Santos Antonio A   Del Carmen DeMingo-Alemany Maria M   Moreno-Macián Francisca F   Roselló Mónica M   Orellana Carmen C   Martínez Francisco F   Caro-Llopis Alfonso A   León-Cariñena Sara S   Tomás-Vila Miguel M  

International journal of endocrinology and metabolism 20180701 3


<h4>Introduction</h4>Schaaf-Yang syndrome (SYS) is caused by truncating point mutations of the paternal allele of <i>MAGEL2</i>, an imprinted gene located in the critical region of Prader-Willi syndrome (PWS). These patients present a phenotype with neurodevelopmental delay, hypotonia, joint contractures, and a particularly high prevalence of autism (up to 75% in affected individuals). The loss of function of <i>MAGEL2</i> is suggested to contribute to endocrine hypothalamic dysfunction in indiv  ...[more]

Similar Datasets

| S-EPMC5456300 | biostudies-literature
| S-EPMC9184671 | biostudies-literature
| S-EPMC9922728 | biostudies-literature
| S-EPMC5345063 | biostudies-literature
| S-EPMC8350409 | biostudies-literature
| S-EPMC7574436 | biostudies-literature
| S-EPMC10777220 | biostudies-literature
| S-EPMC6585857 | biostudies-literature
| S-EPMC8757634 | biostudies-literature
| S-EPMC10724517 | biostudies-literature